Schedule 13D ownership disclosure

REGENERON PHARMACEUTICALS COM

Security class unavailable · CUSIP: 75886F107

Event date: 2014-07-07

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
21.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001140361-14-028082
Form type
SC 13D/A
Filer
REGENERON PHARMACEUTICALS, INC.
CIK
CIK 872589
Filed
Jul 09, 2014
Reporting period
Jul 07, 2014
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub